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ABSTRACT 
 
Cell-mediated xenograft rejection, including NK cells and CD8+ CTL, is a major obstacle 25 
in successful pig-to-human xenotransplantation. Human CD8+ CTL and NK cells display high 
cytotoxicity for pig cells, mediated at least in part by the Fas/FasL pathway. To prevent cell-
mediated xenocytotoxicity, a membrane-bound form of human FasL (mFasL) was generated 
as an inhibitor for CTL and NK cell cytotoxicity that could not be cleaved 
by metalloproteinase to produce putative soluble FasL. We produced two healthy transgenic 30 
pigs harboring the mFasL gene via somatic cell nuclear transfer (SCNT). In a cytotoxicity 
assay using transgenic clonal cell lines and transgenic pig ear cells, the rate of CD8+ CTL-
mediated cytotoxicity was significantly reduced in transgenic pig's ear cells compared with 
that in normal minipig fetal fibroblasts. Our data indicate that grafts of transgenic pigs 
expressing membrane-bound human FasL control the cellular immune response to xenografts, 35 
creating a window of opportunity to facilitate xenograft survival. 
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Introduction 45 
 
A major well-known immunological barrier to xenotransplantation of pig organs into humans is 
the binding of human natural anti-Gal antibody to α-gal epitopes (Galα1-3Galβ1-4GlcNAc-R) 
abundantly expressed on pig cells, inducing complement activation, hyperacute rejection, and acute 
vascular rejection of the xenograft.1 Generation of an α-1,3-galactosyltransferase gene-knockout 50 
pigs may aid in overcoming this antibody-mediated hyperacute rejection.2 Once hyperacute 
rejection is overcome, xenografts are rejected directly due to immunity mediated by cells including 
NK cells and CD8+ CTL.3,4,5,6 Previous studies have demonstrated that human CD8+ CTL directly 
recognizes MHC classⅠ (SLA-Ⅰ) on pig endothelial cells, which have the ability to directly kill 
xenograft cells in xenograft recipients.5,6 These findings indicate that human CD8+ CTL-mediated 55 
cytotoxicity in xenograft recipients is a new immunologic barrier for successful pig-to-human 
xenotransplantation. In the present study, we aimed to produce transgenic pigs in which this CTL-
mediated response against xenograft cells is blocked, and assess the mechanism underlying direct 
destruction of xenograft cells by human CD8+ CTL. 
Studies with mice deficient in perforin/granzyme or FasL have indicated that the 60 
perforin/granzyme and FasL systems are the major pathways for CTL-mediated cytotoxicity.7,8,9 
CD8+ CTL predominantly uses the Fas/FasL pathway to kill xenografted cells.6 
Fas (CD95), a type I transmembrane protein and a member of the tumor necrosis factor (TNF) 
receptor family, is expressed on a variety of hematopoietic cells, including activated NK and T cells, 
monocytes and polymorphonuclear neutrophilic leukocytes (PMN), as well as hepatocytes and 65 
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certain tumor cells.10 On the other hand, the expression of FasL (CD178), a type Ⅱ membrane 
protein, is more restricted and involves activated cytotoxic T lymphocytes (CTL),11 NK cells,12 and 
cells in ‘immune privileged’ sites.10,13 Fas-expressing cells undergo apoptosis upon interactions with 
FasL.10 
One valuable strategy for inhibiting the xenocytotoxic activity of human CTL involves the 70 
expression of human FasL on pig xenograft cells to kill human CTL via activation of human Fas.14 
However, this technique fails to protect xenograft cells because strong chemotaxis of human 
polymorphonuclear neutrophils is induced by soluble FasL released from cells expressing 
ligand.15,16 In the present study, membrane-bound human FasL, which is not cleaved to the soluble 
form of FasL by metalloproteinase, was used to inhibit human CTL cytotoxicity against xenograft 75 
cells. 
Pigs are useful in biomedical research due to their anatomic and physiologic similarities to 
humans.17 In particular, miniature pigs are extensively used owing to their smaller body size18 and 
well-defined genetic background,19 compared with domestic pigs, including Landrace, Yorkshire, 
Duroc, and their hybrids. However, domestic pigs have the advantage of lower cost, higher 80 
prolificacy and wide availability.20 
One of the most remarkable research fields using miniature pigs is xenotransplantation. 
Transgenic pigs have been produced for this purpose using the somatic cell nuclear transfer (SCNT) 
technique.21 Recent advances in genetic engineering technology, particularly using SCNT, has 
allowed the generation of genetically modified miniature pigs for the development of 85 
xenotransplantation.22,23 Limited information is available on SCNT clones using donor cells from 
miniature pigs.23,24 Numerous factors affect the efficiency of SCNT in the pig, including SCNT 
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procedure,25,26 artificial activation conditions,27,28,29 stages of donor cells.30 
In the case of SCNT miniature pig embryos, it is reasonable to use IVM oocytes derived from 
domestic pig ovaries, which are easily available from the slaughterhouse. Recent studies have 90 
shown that nuclear-cytoplasmic compatibility between different species or strains exerts a profound 
effect on the development of SCNT embryos,31,32 indicating that hybrid embryos reconstructed from 
the donor nuclei of miniature pigs with domestic pig cytoplasts display different developmental 
outcomes in a cell source-specific manner. 
A previous investigation on in vivo-generated embryos reports that both placenta development 95 
and maintenance of pregnancy are influenced by fetal and maternal breed.33 Here, we hypothesize 
that breed differences between cell donors and recipients is an important factor affecting the success 
of cloning of miniature pigs. 
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 110 
RESULTS 
 
Establishment of cells expressing human FasL 
 
Miniature pig fetal fibroblasts were transfected with pcDNA/FasL vector. Transfected cells were 115 
selected using hygromycin (200 ㎍/㎖) for 2 weeks, and selected colonies were screened for the 
presence of the FasL gene using PCR. A stable cell line positive for wild-type FasL (W1-1) and two 
clones positive for mFasL (F3-140 and F4-41) were established for the transgenic clonal cell lines. 
Transgene expression was analyzed using FACS and immunocytochemistry analyses. A normal 
porcine cell line and three FasL-transfected clonal cell lines were analyzed by FACS with mouse 120 
anti-human Fas ligand to determine the surface expression profiles of wild-type and mutant 
FasL.  FACS analysis revealed high FasL expression in transgenic clonal cells (Fig. 1a-c). FasL 
expression in transgenic clonal cell lines was increased, relative to that in normal fetal cells. 
Immunocytochemistry experiments indicated strong FasL staining in all transgenic clonal cell lines 
(Fig. 2). The presence of the human FasL gene in genomic DNA of the clonal cell lines was 125 
confirmed using FISH. F4-41 cells were identified as stable transgenic cells, while others were 
mixed with non-transgenic cells. The F4-41 cell line displayed a normal chromosome number 
(36,XX). The integration site on the chromosome in F4-41 was 3p17. Accordingly, nuclear transfer 
was performed using F4-41 transgenic cells as the nuclear donor. 
 130 
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Production of transgenic cloned pigs 
 
Cloned miniature piglets can be produced using both miniature and domestic pig recipients 135 
(Table 1). Pregnancy rates after transferring cloned miniature pig embryos into recipient pigs were 
higher in miniature than domestic recipients. However, delivery rates of miniature pig embryos 
transferred to domestic pig recipients were significantly higher than the rates of those transferred to 
miniature pig recipients. Domestic recipient pigs delivered one healthy female piglet and two 
stillborn piglets. The miniature recipient also delivered one healthy female piglet. No abnormalities 140 
were observed upon initial physical examination of the piglets. The presence of the mFasL gene in 
individual piglets was confirmed by PCR using DNA from the umbilical cord (Fig. 3a). Analysis of 
ear cells using FISH probes for the membrane-bound FasL gene revealed transgene integration in all 
piglets identical to that observed in metaphase spreads derived from the F4-41 cell line (Fig. 3b,c). 
Transgene expression was analyzed using FACS. Transgenic pig ear fibroblasts were prepared from 145 
transgenic piglets at 30 days after birth. FACS analysis revealed a slightly lower mFasL level in 
transgenic piglet ear cells than in donor cells. However, we observed stable expression of mFasL 
(Fig. 1d). 
The 11 microsatellite markers were used for differentiating between donor cell lines as well as 
recipients. As shown in Table 2, nuclear DNA genotypes were identical between the cell lines and 150 
SCNT clones, but differed from those of the surrogate recipients. Our data confirm that the piglets 
obtained are derived from the cell lines used for SCNT. 
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Phenotype analysis of cultured lymphocytes 
Although all subpopulations were detected among fresh lymphocytes, the majority (>80%) of 155 
lymphocytes cultured for 14 days were CD8+ T cells and small amounts (<20%) were positive for 
the anti-CD56 antibody. B cells and macrophages were not detected among the cultured 
lymphocytes (Fig. 4a). Furthermore, CD8+ CTLs present in 14-day cultures were confirmed as T 
cells capable of killing porcine fibroblasts following isolation using magnetic beads (Fig. 4b). Our 
findings indicate that strong cytotoxicity of cultured lymphocytes is associated with the CD8+ T 160 
population. 
 
Overexpression of mFasL effectively prevents CD8+ CTL-mediated cytotoxicity against ear 
fibroblasts from transgenic piglet 
 165 
Freshly obtained lymphocytes from healthy donors displayed no cytotoxic activity towards 
normal mini-pig cells. However, cells cultured for 14 days had highly detrimental effects. 
Furthermore, strong cytotoxicity against mini-pig fibroblasts was associated with CD8+ 
lymphocytes. Downregulation of CTL-mediated directed cell lysis by mFasL was observed in two 
clonal cell lines and transgenic piglet ear fibroblast cells. Overexpression of membrane-bound FasL 170 
in transgenic mini-pig ear fibroblasts resulted in marked cytoprotection from CD8+ CTL 
activity. The rate of CTL cytotoxicity was reduced to 38.4±19.2% compared with the control (60.8 
± 11.3%) at a 5:1 E/T ratio, and reduced to 31.2±47.4% compared with the control (72.5±31.9%) at 
a 10:1 E/T ratio (Fig. 5). This finding indicates that beneficial effects of inhibition of CD8+ CTL-
mediated xenocytotoxicity and is elicited by expression of membrane-bound FasL in transgenic 175 
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mini-pigs. 
DISCUSSION 
 
In the present study, transgenic miniature pigs with membrane-bound human FasL gene were 
successfully produced. Moreover, overexpression of membrane-bound FasL on transgenic pig cells 180 
prevented human CTL-mediated cytotoxicity. In transgenic pig ear cells, cytotoxicity was 
significantly suppressed at effector:target ratios of 5:1 and 10:1. This finding indicates that 
expression of membrane-bound FasL molecules on the pig cell surface is required to bind the 
human Fas receptor, which is sufficient for protection against CTL killing. 
Previous studies indicated that human CD8+ CTL-mediated killing by xenograft recipients 185 
represents an immunological barrier because these are highly toxic to pig xenograft cells.6 Our 
results additionally demonstrate activation of CD8+ CTL that directly kill xenograft target cells in 
vitro. Incubation of lymphocytes with pig primary cells, followed by the addition of IL-2 after 3 
days, resulted in the emergence of a CD8+ T cell population comprising more than 80% of cultures 
incubated for 14 days (Fig. 4a). These CD8+ CTL predominantly use the Fas/FasL pathway to kill 190 
xenografted cells.6 Binding of FasL to Fas induces formation of the death-inducing signaling 
complex (DISC), which contains the Fas receptor as well as several signaling components, such as 
Fas-associated death domain (FADD) and caspase 8, which destroy the cells.38 A membrane-bound 
form of human FasL with a serial deletion at the cytoplasmic region and the metalloproteinase 
cleavage site was constructed with the intention of inhibiting human CTL cytotoxicity. Human FasL 195 
is a type Ⅱ membrane protein with a proline-rich amino terminal cytoplasmic region.39 Tanaka et 
al.35 reported that the introduction of intact human FasL cDNA into various cell lines did not 
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generate stable transformants expressing high levels of FasL. This may be due to destabilization of 
FasL on the cell surface by the proline-rich sequence. Deletion of residues 8 to 69 induced 
overexpression of human FasL. FasL is cleaved by a metalloproteinase to produce the soluble form 200 
(sFasL), which is functional in inducing apoptosis. Tanaka and colleagues produced mFasL by 
deleting the cleavage site (residues 110 to 134).36 Upon binding of TNF to its receptor, the complex 
is internalized and degraded, leading to receptor downregulation.40 The sFasL/Fas complex may be 
easily internalized, whereas internalization of mFasL with Fas is likely to be retarded.  
The mFasL gene was transfected into miniature pig fetal fibroblasts for producing transgenic 205 
clonal cells. The F4-41 clonal cell line was selected as a nuclear transfer donor cells using PCR, 
FACS, immunocytochemistry, and FISH analyses. Two healthy transgenic miniature pigs with 
mFasL were produced via SCNT. Expression of mFasL was low in transgenic pig ear cells 
compared with that in donor and other clonal types (Fig. 1). At present, the reason for the difference 
in expression levels in these cells is unknown, but may be due to the integration site or epigenetic 210 
modification of the transgene. Especially, Kang and colleagues reported that tissue-specific 
expression of the transgene correlates with DNA demethylation at specific CpG sites as well as 
significant changes in histone modification.41 Although mFasL expression was low in transgenic ear 
cells, cytotoxicity was significantly reduced in transgenic pig cells compared with the control at 
effector:target ratios of 5:1 and 10:1 (Fig. 5). Our data are consistent with previous studies showing 215 
that mFasL overexpression on porcine endothelial cells and pig islet xenografts significantly 
suppressed human CTL cytotoxicity at low mFasL level.42,43,44,45 CTL cytotoxicity was suppressed 
in the majority of transgenic clonal cell lines, but was still higher than that in transgenic pig ear 
cells. This may be attributed to senescence of the clonal cell line during transfection, drug selection 
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or other passing conditions for establishing transgenic clonal cell lines. These data indicate that 220 
xenograft cells isolated from transgenic pigs with mFasL control the cellular immune response to 
xenografts. 
Our study demonstrates that transgenic cloned miniature pigs can be produced using both 
miniature and domestic pig recipients (Table 1). Using miniature pig cells as nuclear donors, we 
obtained pregnancy rates of 16% and 35% in miniature and domestic recipient animals, respectively. 225 
The production efficiency of cloned piglets using common domestic pigs as recipients tended to be 
higher, although no clear statistical differences were evident due to the small number of transfer 
experiments. In particular, miniature pig SCNT clones displayed considerably more fetal lethality at 
day 45 of gestation. Our findings were consistent with those of a previous study performed with 
Yucatan using SCNT embryos.46 In view of resorbing around implantation periods, Yucatan SCNT 230 
clones have considerably more fetal lethality at day 30 of gestation. The placentas of Yucatan SCNT 
clones are smaller than those of occidental breed clones, which may contribute to the higher fetal 
mortality in Yucatan. Moreover, Ueno et al. suggested the possibility of embryonic loss in 
transferring cloned embryos with damaged zona pellucida to the oviduct.47 Overall, reduced 
efficiencies in the miniature pig are unlikely to be an issue of technical variability or oocyte or 235 
recipient quality because higher efficiencies with domestic breeds using analogous oocyte sources 
as donors and the same recipient herd were obtained by our group.48 Lower viability of the 
miniature pig is caused by factors other than experimental variability. These factors, including 
mitochondrial incompatibility and reduced compatibility between the miniature pig placenta and 
domestic uterine environment, remain to be fully characterized. According to previous studies 240 
performed with Meishan and Yorkshire pigs using in vivo fertilized embryos, pregnancy rates were 
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determined by the uterine environment up to day 90 of gestation, regardless of the fetal genotype. 
33,49 Recently, domestic pigs were recommended as an embryo recipient for production of cloned 
miniature pigs due to their ability to accommodate more fetuses.50 Compared with common 
domestic pigs, miniature pigs produce fewer piglets and production costs are higher. Consequently, 245 
establishing a mass production system for cloned miniature pigs using IVM oocytes derived from 
abattoir ovaries should further accelerate the usage of miniature pigs in this field.  
To our knowledge, this is the first report to describe the generation of pigs containing transgenes 
of membrane-bound human FasL. Overexpression of mFasL on xenograft cells leads to strong 
protection against human CTL killing that may subsequently control the cellular response to 250 
xenografts and thus creates a window of opportunity to facilitate xenograft survival. In the present 
study, the SCNT technique originally developed for common domestic pigs was applied to 
miniature pigs, with efficient production of reconstructed embryos. Furthermore, our findings 
indicate both miniature and common domestic pig recipients can be effectively used for the 
production of transgenic cloned miniature pigs. 255 
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FIGURE LEGENDS 
 420 
Figure 1. Overexpression of wild-type FasL or mFasL on transgenic clonal cell lines. Normal 
minipig fetal fibroblasts (open histogram) and transgenic cells expressing wild-type FasL or mFasL 
(closed histogram) were stained with mouse anti-human FasL Ab and FITC-conjugated anti-mouse 
IgG Ab, and analyzed using flow cytometry, as described in the Methods section. Mean 
fluorescence intensities of stained cells are expressed in the upper right region of the histogram. a; 425 
transfected with wild type FasL (W1-1), b and c; transfected with membrane-bound FasL (F3-140 
and F4-41), d; transgenic pig ear cells. 
 
Figure 2. FasL expression on the clonal cell surface via immunocytochemistry. Images were 
obteined under bright fields (a,d,g,j), fluorescent fields (b,e,h,k), and merge (c,f,i,l). Normal cells (a-430 
c); non-transfected fetal fibroblasts, W1-1 (d-f); transfected with wild type FasL , F3-140 (g-i) and 
F4-41 (j-l); transfected with membrane-bound FasL. Original magnification ×100. 
 
Figure 3. PCR identification and fluorescence in situ hybridization (FISH) of the mFasL gene in 
transgenic piglets. Genomic DNA was subjected to PCR (a) using a specific primer set for mFasL. 435 
FISH analysis using a rhodamine-labeled probe containing the human FasL gene (b) and 
karyotyping revealed integration of cells obtained from transgenic cloned pigs (c) with normal 
karyotype (d). 
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Figure 4. Phenotype of human lymphocytes. Human lymphocytes were prepared from the 440 
peripheral blood of healthy volunteers by density centrifugation through Ficoll. Human 
lymphocytes were cultured at 37℃ for 14 days with IL-2. To determine the profile of human 
lymphocytes after culture, cells were stained with PE-conjugated anti-CD8+, CD19, CD11 and 
CD56, respectively (a). To isolate CD8+ lymphocytes, cells were incubated with CD8+ DynaBeads 
for 20 min at 4℃. After isolation, cells were stained with PE-conjugated anti-CD8+ (b). 445 
 
Figure 5. The cytoprotective effect of FasL expression on miniature pig cells against human CD8+ 
lymphocytes. The cytotoxicity assay was performed in cultured CD8+ lymphocytes from healthy 
volunteers. Effector cell and target cell ratios are 5:1 (closed circles) and 10:1 (open circles), 
respectively. Negative control; non-transfected fetal fibroblasts, F4-41; donor cell, W3-104; 450 
transfected with wild-type FasL, Transgenic pig; transgenic cloned miniature pig ear cells. 
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Figure 1. 
 
 465 
Figure 2. 
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Figure 3. 
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Figure 4. 480 
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Table 1. In vivo development of cloned porcine embryos derived from fetal fibroblasts of 485 
miniature pig and transferred to miniature or domestic recipient pigs 
 
Donor cell 
Recipient 
Breed 
No. of 
recipients 
Pregnancy (%) Delivery (%) 
No. of piglets 
(Stillborn) 
F4-41 
Miniature 14 5 (35) 1 (7) 1 
Domestic 6 1 (16) 1 (16) 1 (2) 
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 500 
 
Table 2. Microsatellite (MS) analysis of clonal cell line, surrogates and pigletsa 
 
Markers Donor cell 1st surrogate 1st piglet 2nd surrogate 2nd piglet 
S0005 222/246 222/246 222/246 236/242 222/246 
S0026 100/104 104/106 100/104 100/106 100/104 
S0155 165/167 163/165 165/167 165/165 165/167 
S0225 186/186 186/192 186/186 174/192 186/186 
SW122 120/120 120/120 120/120 122/128 120/120 
SW24 104/118 130/130 104/118 118/124 104/118 
SW632 168/168 168/176 168/168 178/178 168/168 
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SW72 105/125 105/107 105/125 115/115 105/125 
SW787 150/164 152/158 150/164 162/166 150/164 
SW939 118/118 118/118 118/118 100/114 118/118 
SW951 129/139 129/139 129/139 127/131 129/139 
 
a For each microsatellite marker, genotype was determined by size (base pairs). Litter 2 results 505 
from markers provide the strongest support for the genetic identity of fetal fibroblasts by 
donor cells (F4-41) and nuclear transfer piglets. 
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